Back
iShares Emerging Markets Dividend ETF Vs. Exelixis, Inc. Sector Stock Comparison
Sell
46
DVYE
iShares Emerging Markets Dividend ETF
Last Price:
$31.17
Seasonality Move:
-0.16%
Buy
74
EXEL
Exelixis, Inc.
Last Price:
$44.44
Seasonality Move:
2.88%
Sell
46
iShares Emerging Markets Dividend ETF (DVYE)
is a Sell
Is iShares Emerging Markets Dividend ETF a Buy, Sell or Hold?
-
The current iShares Emerging Markets Dividend ETF [DVYE] share price is $31.07. The Score for DVYE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
DVYE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Exelixis, Inc. (EXEL)
is a Buy
Is Exelixis, Inc. a Buy, Sell or Hold?
-
The current Exelixis, Inc. [EXEL] share price is $45.37. The Score for EXEL is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
EXEL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DVYE Stock Price Chart
What is iShares Emerging Markets Dividend ETF's stock price today?
-
The iShares Emerging Markets Dividend ETF share price today is $31.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DVYE is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXEL Stock Price Chart
What is Exelixis, Inc.'s stock price today?
-
The Exelixis, Inc. share price today is $45.37The current trend is moderately bullish and EXEL is experiencing selling pressure, which indicates risk of future bearish movement.
DVYE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 53.41 | Buy |
| Chaikin Money Flow: | 81730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.69 - 31.25) | Buy |
| Bollinger Bands (100): | (29.53 - 30.97) | Buy |
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 61.42 | Buy |
| Chaikin Money Flow: | -1567166 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.7 - 45.18) | Buy |
| Bollinger Bands (100): | (37.72 - 42.76) | Buy |
DVYE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.83 | Buy |
| 20-day SMA: | 31.01 | Buy |
| 50-day SMA: | 30.83 | Buy |
| 200-day SMA: | 29.08 | Buy |
| 8-day EMA: | 30.96 | Buy |
| 20-day EMA: | 30.95 | Buy |
| 50-day EMA: | 30.73 | Buy |
| 200-day EMA: | 29.42 | Buy |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.97 | Buy |
| 20-day SMA: | 43.49 | Buy |
| 50-day SMA: | 41.7 | Buy |
| 200-day SMA: | 40.27 | Buy |
| 8-day EMA: | 45.06 | Buy |
| 20-day EMA: | 43.83 | Buy |
| 50-day EMA: | 42.36 | Buy |
| 200-day EMA: | 39.48 | Buy |
iShares Emerging Markets Dividend ETF Earnings Growth & DVYE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Exelixis, Inc. Earnings Growth & EXEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.37 per share.
iShares Emerging Markets Dividend ETF Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Exelixis, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||